Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Endocrinology Hormones Reagents Market by Type (Follicle-stimulating Hormone, Luteinizing Hormone, Progesterone, Growth Hormone, Others), By Application (Hospital, Scientific Research) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Endocrinology Hormones Reagents Market by Type (Follicle-stimulating Hormone, Luteinizing Hormone, Progesterone, Growth Hormone, Others), By Application (Hospital, Scientific Research) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 341269 4200 Chemical & Material 377 218 Pages 4.6 (49)
                                          

Market Overview:


The global endocrinology hormones reagents market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of endocrine disorders, rising demand for precision medicine, and technological advancements in the field of endocrinology. Based on type, the follicle-stimulating hormone (FSH) segment is expected to account for the largest share of the global endocrinology hormones reagents market in 2018. This segment is anticipated to grow at a CAGR of 7% during the forecast period. FSH plays an important role in regulating ovarian function and fertility. It is also used as a marker for assessing ovarian reserve and response to ovulation induction therapy.


Global Endocrinology Hormones Reagents Industry Outlook


Product Definition:


Endocrinology is the study of hormones and their interactions with cells and tissues. Hormones are important for regulating metabolism, growth, development, and reproduction. Reagents are used in endocrinology to measure hormone levels in blood or other body fluids.


Follicle-stimulating Hormone:


Follicle-stimulating hormone (FSH) is a glycoprotein hormone produced by the anterior pituitary gland in response to stimulation of the Follicle Stimulating Gland (FSG). It is important for growth and development of cells in the thyroid, ovary, and adrenal glands.


Luteinizing Hormone:


Luteinizing hormone (LH) is a glycoprotein released by the pituitary gland in response to stimulation of the ovary. It acts on the target cells to trigger the production of vitamin A and allows for vision correction, cell growth & differentiation, and proper body functioning.


Application Insights:


The scientific research segment dominated the global endocrinology hormones reagents market in 2017. This is owing to a rise in R&D activities pertaining to the development of new diagnostics and therapeutics for various endocrine disorders. In addition, an increase in government funding for research related to hormones has also positively influenced the growth of this segment.


Hospital application is expected to witness significant growth over the forecast period due largely on a rise in prevalence of chronic diseases such as diabetes and cancer that require regular monitoring and treatment with hormone therapy drugs.


Regional Analysis:


North America dominated the global endocrinology hormones reagents market in 2017. The presence of key players, advanced healthcare infrastructure and high prevalence of target diseases are some factors responsible for its large share. In addition, increasing R&D activities to develop novel products is expected to drive the regional growth over the forecast period.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare facilities in emerging countries such as China and India.


In 2016, Japan was one of largest markets for these products due to a rise in aging population with various associated disorders such as diabetes & obesity (insulin resistance), osteoporosis (men), breast cancer (women) 9 which require long-term hormone replacement therapy 10 or other endocrine therapies 11 .


Growth Factors:


  • Increasing incidence of endocrine disorders: The global incidence of endocrine disorders is increasing at a rapid pace. This is primarily attributed to the changing lifestyle and dietary habits. This, in turn, is fueling the demand for endocrinology hormones reagents.
  • Growing awareness about endocrine disorders: There is a growing awareness among people about the various types of endocrine disorders and their symptoms. This is helping to create a larger pool of potential patients for treatment with endocrinology hormones reagents.
  • Technological advancements in hormone testing: There have been significant advancements in technology for hormone testing in recent years. This has helped to improve the accuracy and precision of hormone tests, thus driving demand for Endocrinology Hormones Reagents market .

Scope Of The Report

Report Attributes

Report Details

Report Title

Endocrinology Hormones Reagents Market Research Report

By Type

Follicle-stimulating Hormone, Luteinizing Hormone, Progesterone, Growth Hormone, Others

By Application

Hospital, Scientific Research

By Companies

Roche, BCI, Siemens, Abbott, Tosoh, Snibe Diagnostic, Adaltis, Wantai BioPharm, Biocell, EasyDiagnosis Biomedicine, DRG International

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

218

Number of Tables & Figures

153

Customization Available

Yes, the report can be customized as per your need.


Global Endocrinology Hormones Reagents Market Report Segments:

The global Endocrinology Hormones Reagents market is segmented on the basis of:

Types

Follicle-stimulating Hormone, Luteinizing Hormone, Progesterone, Growth Hormone, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Scientific Research

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Roche
  2. BCI
  3. Siemens
  4. Abbott
  5. Tosoh
  6. Snibe Diagnostic
  7. Adaltis
  8. Wantai BioPharm
  9. Biocell
  10. EasyDiagnosis Biomedicine
  11. DRG International

Global Endocrinology Hormones Reagents Market Overview


Highlights of The Endocrinology Hormones Reagents Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Follicle-stimulating Hormone
    2. Luteinizing Hormone
    3. Progesterone
    4. Growth Hormone
    5. Others
  1. By Application:

    1. Hospital
    2. Scientific Research
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Endocrinology Hormones Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Endocrinology Hormones Reagents Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Endocrinology hormones reagents are chemicals that are used to study the effects of hormones on cells and tissues.

Some of the major companies in the endocrinology hormones reagents market are Roche, BCI, Siemens, Abbott, Tosoh, Snibe Diagnostic, Adaltis, Wantai BioPharm, Biocell, EasyDiagnosis Biomedicine, DRG International.

The endocrinology hormones reagents market is expected to register a CAGR of 6.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endocrinology Hormones Reagents Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Endocrinology Hormones Reagents Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Endocrinology Hormones Reagents Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Endocrinology Hormones Reagents Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Endocrinology Hormones Reagents Market Size & Forecast, 2020-2028       4.5.1 Endocrinology Hormones Reagents Market Size and Y-o-Y Growth       4.5.2 Endocrinology Hormones Reagents Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Follicle-stimulating Hormone
      5.2.2 Luteinizing Hormone
      5.2.3 Progesterone
      5.2.4 Growth Hormone
      5.2.5 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Scientific Research
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Endocrinology Hormones Reagents Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Endocrinology Hormones Reagents Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Follicle-stimulating Hormone
      9.6.2 Luteinizing Hormone
      9.6.3 Progesterone
      9.6.4 Growth Hormone
      9.6.5 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Scientific Research
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Follicle-stimulating Hormone
      10.6.2 Luteinizing Hormone
      10.6.3 Progesterone
      10.6.4 Growth Hormone
      10.6.5 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Scientific Research
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Follicle-stimulating Hormone
      11.6.2 Luteinizing Hormone
      11.6.3 Progesterone
      11.6.4 Growth Hormone
      11.6.5 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Scientific Research
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Follicle-stimulating Hormone
      12.6.2 Luteinizing Hormone
      12.6.3 Progesterone
      12.6.4 Growth Hormone
      12.6.5 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Scientific Research
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Follicle-stimulating Hormone
      13.6.2 Luteinizing Hormone
      13.6.3 Progesterone
      13.6.4 Growth Hormone
      13.6.5 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Scientific Research
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Endocrinology Hormones Reagents Market: Competitive Dashboard
   14.2 Global Endocrinology Hormones Reagents Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Roche
      14.3.2 BCI
      14.3.3 Siemens
      14.3.4 Abbott
      14.3.5 Tosoh
      14.3.6 Snibe Diagnostic
      14.3.7 Adaltis
      14.3.8 Wantai BioPharm
      14.3.9 Biocell
      14.3.10 EasyDiagnosis Biomedicine
      14.3.11 DRG International

Our Trusted Clients

Contact Us